Works matching IS 13866346 AND DT 2023 AND VI 53 AND IP 5

Results: 10

Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH‐HCC Guidelines).

Published in:

Hepatology Research, 2023, v. 53, n. 5, p. 383, doi. 10.1111/hepr.13892

By:

Hasegawa, Kiyoshi;
Takemura, Nobuyuki;
Yamashita, Tatsuya;
Watadani, Takeyuki;
Kaibori, Masaki;
Kubo, Shoji;
Shimada, Mitsuo;
Nagano, Hiroaki;
Hatano, Etsuro;
Aikata, Hiroshi;
Iijima, Hiroko;
Ueshima, Kazuomi;
Ohkawa, Kazuyoshi;
Genda, Takuya;
Tsuchiya, Kaoru;
Torimura, Takuji;
Ikeda, Masafumi;
Furuse, Junji;
Akahane, Masaaki;
Kobayashi, Satoshi

Publication type:

Article

Multicenter, retrospective, cohort study shows platelet counts predict hepatocellular carcinoma development in patients with nonalcoholic fatty liver disease.

Published in:

Hepatology Research, 2023, v. 53, n. 5, p. 391, doi. 10.1111/hepr.13884

By:

Fujii, Hideki;
Fujii, Makoto;
Iwaki, Michihiro;
Hayashi, Hideki;
Toyoda, Hidenori;
Oeda, Satoshi;
Hyogo, Hideyuki;
Kawanaka, Miwa;
Morishita, Asahiro;
Munekage, Kensuke;
Kawata, Kazuhito;
Tsutsumi, Tsubasa;
Sawada, Koji;
Maeshiro, Tatsuji;
Tobita, Hiroshi;
Yoshida, Yuichi;
Naito, Masafumi;
Araki, Asuka;
Arakaki, Shingo;
Kawaguchi, Takumi

Publication type:

Article

Quality of life in Dutch patients with primary biliary cholangitis: Discrepancies between patients' perspectives and objective disease parameters.

Published in:

Hepatology Research, 2023, v. 53, n. 5, p. 401, doi. 10.1111/hepr.13880

By:

de Veer, Rozanne C.;
van Hooff, Maria C.;
da Silva, Geraldine;
Harms, Maren H.;
Metselaar, Herold J.;
Willemse, José;
Utomo, Elaine;
van der Meer, Adriaan J.

Publication type:

Article

Navitoclax improves acute‐on‐chronic liver failure by eliminating senescent cells in mice.

Published in:

Hepatology Research, 2023, v. 53, n. 5, p. 460, doi. 10.1111/hepr.13879

By:

Watanabe, Yusuke;
Abe, Hiroyuki;
Kimura, Naruhiro;
Arao, Yoshihisa;
Ishikawa, Natsuki;
Yuichiro, Maeda;
Setsu, Toru;
Sakamaki, Akira;
Kamimura, Hiroteru;
Yokoo, Takeshi;
Kamimura, Kenya;
Tsuchiya, Atsunori;
Terai, Shuji

Publication type:

Article

Factors associated with liver injury and prognosis in advanced cancer patients treated with immune checkpoint inhibitors.

Published in:

Hepatology Research, 2023, v. 53, n. 5, p. 450, doi. 10.1111/hepr.13878

By:

Kaneko, Shun;
Asahina, Yasuhiro;
Nakagawa, Mina;
Murakawa, Miyako;
Miyazaki, Yasunari;
Asakage, Takahiro;
Fukuda, Shohei;
Namiki, Takeshi;
Kano, Yoshihito;
Nagata, Masashi;
Tsuchiya, Jun;
Miyoshi, Masato;
Kitahata‐Kawai, Fukiko;
Nitta, Sayuri;
Itsui, Yasuhiro;
Kakinuma, Sei;
Okamoto, Ryuichi

Publication type:

Article

The imbalance between NKG2A and NKG2D expression is involved in NK cell immunosuppression and tumor progression of patients with hepatitis B virus‐related hepatocellular carcinoma.

Published in:

Hepatology Research, 2023, v. 53, n. 5, p. 417, doi. 10.1111/hepr.13877

By:

Yu, Lihua;
Sun, Lei;
Liu, Xiaoli;
Wang, Xinhui;
Yan, Huiwen;
Pu, Qing;
Xie, Yuqing;
Jiang, Yuyong;
Du, Juan;
Yang, Zhiyun

Publication type:

Article

Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: Final results of a multicenter phase II study.

Published in:

Hepatology Research, 2023, v. 53, n. 5, p. 409, doi. 10.1111/hepr.13876

By:

Kato, Naoya;
Kudo, Masatoshi;
Tsuchiya, Kaoru;
Hagihara, Atsushi;
Numata, Kazushi;
Aikata, Hiroshi;
Inaba, Yoshitaka;
Kondo, Shunsuke;
Motomura, Kenta;
Okano, Naohiro;
Ikeda, Masafumi;
Morimoto, Manabu;
Kuroda, Shingo;
Kimura, Akiko

Publication type:

Article

Prognostic significance for recurrence of fibroblast growth factor receptor 2 in intrahepatic cholangiocarcinoma patients undergoing curative hepatic resection.

Published in:

Hepatology Research, 2023, v. 53, n. 5, p. 432, doi. 10.1111/hepr.13875

By:

Toshida, Katsuya;
Itoh, Shinji;
Yugawa, Kyohei;
Kosai, Yukiko;
Tomino, Takahiro;
Yoshiya, Shohei;
Nagao, Yoshihiro;
Kayashima, Hiroto;
Harada, Noboru;
Kohashi, Kenichi;
Oda, Yoshinao;
Yoshizumi, Tomoharu

Publication type:

Article

Significant association between HLA‐B*35:01 and onset of drug‐induced liver injury caused by Kampo medicines in Japanese patients.

Published in:

Hepatology Research, 2023, v. 53, n. 5, p. 440, doi. 10.1111/hepr.13874

By:

Nakamura, Ryosuke;
Arakawa, Noriaki;
Tanaka, Yoichi;
Uchiyama, Nahoko;
Sekine, Akihiro;
Mashimo, Yoichi;
Tsuji, Keiji;
Kagawa, Tatehiro;
Sato, Ken;
Watanabe, Masaaki;
Aiso, Mitsuhiko;
Hiasa, Yoichi;
Takei, Yoshiyuki;
Ohira, Hiromasa;
Ayada, Minoru;
Tsukagoshi, Eri;
Maekawa, Keiko;
Tohkin, Masahiro;
Saito, Yoshiro;
Takikawa, Hajime

Publication type:

Article

Issue Information.

Published in:: Hepatology Research, 2023, v. 53, n. 5, p. 381, doi. 10.1111/hepr.13782
Publication type:: Article